Reuven Spiegel files Form 144 to sell 10,000 shares

Reuven Spiegel submitted a Form 144 notice to sell 10,000 shares of Common Stock, with a reported aggregate value of $443,600.00.

Rhea-AI Filing Summary

Reuven Spiegel submitted a Form 144 notice to sell 10,000 shares of Common Stock, with a reported aggregate value of $443,600.00. The filing also records prior sales of 20,000 shares on 03/04/2026 for $856,897.52 and scheduled restricted stock vesting events on 12/10/2024, 03/10/2025, and 06/10/2025.

Insights

Insider Transactions Compliance Analyst

Form 144 shows an affiliate-proposed sale of 10,000 shares and prior dispositions in the quarter.

The filing lists a proposed sale of 10,000 shares valued at $443,600.00, and discloses a prior sale of 20,000 shares on 03/04/2026 for $856,897.52. These entries follow standard Form 144 reporting conventions for affiliate transactions.

Cash-flow treatment and broker details are stated for the proposed sale. Subsequent filings or broker reports would record execution details; timing and sale method are not specified in the excerpt.

Key Figures

Proposed sale: 10,000 shares Aggregate value (proposed): $443,600.00 Prior sale (past 3 months): 20,000 shares +4 more

7 metrics

Proposed sale 10,000 shares Form 144 proposed sale, aggregate value listed

Aggregate value (proposed) $443,600.00 Value reported for the 10,000-share proposed sale

Prior sale (past 3 months) 20,000 shares Sold on 03/04/2026 as disclosed in the filing

Proceeds (prior sale) $856,897.52 Proceeds reported for the 20,000-share sale on 03/04/2026

Restricted stock vesting (12/10/2024) 3,119 shares Vesting date listed under Securities Information

Restricted stock vesting (03/10/2025) 5,733 shares Vesting date listed under Securities Information

Restricted stock vesting (06/10/2025) 1,148 shares Vesting date listed under Securities Information

Key Terms

Form 144, Restricted Stock Vesting, Securities Sold During The Past 3 Months

3 terms

Form 144 regulatory

"Form 144 notice to sell 10,000 shares valued at $443,600.00"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Restricted Stock Vesting financial

"Restricted Stock Vesting | Issuer | 03/10/2025 | 5,733"

Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.

Securities Sold During The Past 3 Months regulatory

"Securities Sold During The Past 3 Months | Common | 03/04/2026 | 20,000"

FAQ

What does Reuven Spiegel's Form 144 for DK report?

The Form 144 reports a proposed sale of 10,000 shares valued at $443,600.00. It also discloses a prior sale of 20,000 shares on 03/04/2026 for $856,897.52, plus scheduled vesting events.

How many shares were previously sold by the reporting person?

The filing shows a sale of 20,000 shares on 03/04/2026 for $856,897.52. This prior disposition is reported in the "Securities Sold During The Past 3 Months" section of the Form 144 excerpt.

What vesting events are listed in the filing for DK?

The excerpt lists restricted stock vesting events on 12/10/2024 (3,119 shares), 03/10/2025 (5,733 shares), and 06/10/2025 (1,148 shares). These appear under Securities Information as vesting items.

Does the Form 144 state how the proposed sale will be executed?

The provided excerpt names a broker and reports the proposed sale amount and aggregate value, but it does not specify execution mechanics (block trade, at-the-market, or timing). Execution details would typically appear in subsequent trading or broker confirmations.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/18/2026 - 10:09 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001615515
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Delek US Holdings, Inc.
SEC File Number	001-38142
Address of Issuer	310 SEVEN SPRINGS WAY SUITE 500 BRENTWOOD TENNESSEE 37027
Phone	615-771-6701
Name of Person for Whose Account the Securities are To Be Sold	Spiegel Reuven
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	10000	443600.00	61287542	05/18/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/10/2024	Restricted Stock Vesting	Issuer			3119	12/10/2024	Compensation
Common	03/10/2025	Restricted Stock Vesting	Issuer			5733	03/10/2025	Compensation
Common	06/10/2025	Restricted Stock Vesting	Issuer			1148	06/10/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Reuven Spiegel 310 Seven Springs Way Suite 500 Brentwood TN 37027	Common	03/04/2026	20000	856897.52

144: Remarks and Signature

Remarks
Date of Notice	05/18/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Daniel Tucci, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Reuven Spiegel
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)